Literature DB >> 2153941

Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy.

B V Prasad1, J W Burns, E Marietta, M K Estes, W Chiu.   

Abstract

Three-dimensional structures of several spherical viruses have been determined by electron microscopy and X-ray crystallography. We report here the first three-dimensional structure of the complex between an intact virus and Fab fragments of a neutralizing monoclonal antibody. The antibody is against VP4, one of the two outer capsid proteins of rotaviruses. These large icosahedral viruses cause gastroenteritis in children and young animals and account for over a million human deaths annually. VP4 in these viruses has been implicated in several important functions such as cell penetration, haemagglutination, neutralization and virulence. Here we demonstrate that the surface spikes on rotavirus particles are made up of VP4. Antigenic sites are located near the distal ends of the spikes and two Fab fragments bind to each of the sixty spikes. The mass of the spike indicates that it is a dimer of VP4. The bilobed structure at the distal end of the spike may be involved in both the attachment to the cell and in viral penetration. A novel feature in the virus-Fab complex is the structural difference between the two chemically equivalent Fab fragments on each spike, which could be indicative of variations in the Fab elbow angles.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153941     DOI: 10.1038/343476a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  82 in total

Review 1.  Adding the third dimension to virus life cycles: three-dimensional reconstruction of icosahedral viruses from cryo-electron micrographs.

Authors:  T S Baker; N H Olson; S D Fuller
Journal:  Microbiol Mol Biol Rev       Date:  1999-12       Impact factor: 11.056

2.  Rotavirus spike protein VP4 is present at the plasma membrane and is associated with microtubules in infected cells.

Authors:  M Nejmeddine; G Trugnan; C Sapin; E Kohli; L Svensson; S Lopez; J Cohen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core.

Authors:  P R Dormitzer; H B Greenberg; S C Harrison
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Gerhard Wagner; Stephen C Harrison
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

5.  Trypsin cleavage stabilizes the rotavirus VP4 spike.

Authors:  S E Crawford; S K Mukherjee; M K Estes; J A Lawton; A L Shaw; R F Ramig; B V Prasad
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Structures of rotavirus reassortants demonstrate correlation of altered conformation of the VP4 spike and expression of unexpected VP4-associated phenotypes.

Authors:  Joseph B Pesavento; Angela M Billingsley; Ed J Roberts; Robert F Ramig; B V Venkataram Prasad
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.

Authors:  Juan Ernesto Ludert; Marie Christine Ruiz; Carlos Hidalgo; Ferdinando Liprandi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability.

Authors:  Nina E Golantsova; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope.

Authors:  D Y Chen; M K Estes; R F Ramig
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Interaction of rotavirus particles with liposomes.

Authors:  P Nandi; A Charpilienne; J Cohen
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.